Walter E. Aulitzky
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 46
- Chronic Myeloid Leukemia Treatments 32
- Acute Myeloid Leukemia Research 20
- Oncology 35
- Cancer-related Molecular Pathways 10
- Cancer Immunotherapy and Biomarkers 9
- Co-authors
- Heiko van der Kuip (40 shared papers)Justus Duyster (9 shared papers)Simon Heine (7 shared papers)Moshe Oren (10 shared papers)Kathrin Böpple (6 shared papers)Christian Peschel (12 shared papers)Markus Kleih (7 shared papers)Frank Eßmann (5 shared papers)
- Journals
- Blood (22 papers)Annals of Hematology (8 papers)Cancer Research (7 papers)Journal of Clinical Oncology (5 papers)Cell Death and Disease (5 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Walter E. Aulitzky
118 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 119
- Hematology 1.1k
- Genetics 655
- Oncology 959
- Cancer Research 335
- Pathology and Forensic Medicine 383
Countries citing papers authored by Walter E. Aulitzky
This map shows the geographic impact of Walter E. Aulitzky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter E. Aulitzky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter E. Aulitzky more than expected).
Fields of papers citing papers by Walter E. Aulitzky
This network shows the impact of papers produced by Walter E. Aulitzky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter E. Aulitzky. The network helps show where Walter E. Aulitzky may publish in the future.
Co-authors
The 25 scholars most cited alongside Walter E. Aulitzky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 314 | |
| 2 | 2011 | 170 | |
| 3 | 2005 | 159 | |
| 4 | 1997 | 141 | |
| 5 | 2010 | 127 | |
| 6 | 2003 | 125 | |
| 7 | 2007 | 122 | |
| 8 | 2018 | 94 | |
| 9 | 2006 | 92 | |
| 10 | 2011 | 79 | |
| 11 | 2008 | 78 | |
| 12 | 2000 | 78 | |
| 13 | 2001 | 74 | |
| 14 | 2011 | 71 | |
| 15 | 2012 | 71 | |
| 16 | 2010 | 69 | |
| 17 | The tyrosine kinase inhibitor CGP 57148 (ST1 571) induces apoptosis in BCR-ABL-positive cells by down-regulating BCL-X. | 2000 | 69 |
| 18 | 2016 | 64 | |
| 19 | 2008 | 57 | |
| 20 | 2005 | 57 |
About Walter E. Aulitzky
Walter E. Aulitzky is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Immunology, having authored 122 papers that have together received 3.8k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (32 papers), Chronic Lymphocytic Leukemia Research (24 papers), Acute Myeloid Leukemia Research (20 papers), Eosinophilic Disorders and Syndromes (10 papers), Cancer-related Molecular Pathways (10 papers), Immune Cell Function and Interaction (10 papers), Acute Lymphoblastic Leukemia research (9 papers) and Cancer Immunotherapy and Biomarkers (9 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (655 citations), Oncology (959 citations), Cancer Research (335 citations) and Pathology and Forensic Medicine (383 citations). Walter E. Aulitzky has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Heiko van der Kuip, Justus Duyster, Simon Heine, Moshe Oren, Kathrin Böpple, Christian Peschel, Markus Kleih, Frank Eßmann, Meng Dong and Cornelius Miething. Their work appears in journals such as Blood, Annals of Hematology, Cancer Research, Journal of Clinical Oncology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.